HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance.

AbstractAIMS/HYPOTHESIS:
Vitamin D deficiency may increase the risk of type 2 diabetes. We therefore investigated whether serum concentrations of 25-hydroxyvitamin D [25(OH)D] would predict the development of prediabetes (impaired fasting glucose, impaired glucose tolerance or the two combined) and type 2 diabetes, either on their own or when combined with serum concentrations of IGF-1 or IGF-binding protein-1 (IGFBP-1), which may interact with 25(OH)D.
METHODS:
At baseline, participants aged 35-56 years without known type 2 diabetes were examined using OGTTs, 25(OH)D and IGF peptide measurements, and anthropometric and lifestyle data. Participants who had prediabetes or type 2 diabetes at follow-up 8-10 years later were selected as cases; these were then age- and sex-matched to controls with normal glucose tolerance (NGT) at both baseline and follow-up, giving a total of 980 women and 1,398 men.
RESULTS:
Men but not women in the highest quartile of 25(OH)D level had a decreased OR for developing type 2 diabetes after adjustment for confounders (OR 0.52, 95% CI 0.30, 0.90), an effect accounted for by individuals with prediabetes, but not with NGT, at baseline. In both sexes, progression from prediabetes to type 2 diabetes was reduced by about 25% per 10 nmol/l increase in 25(OH)D. A high IGFBP-1 value was a better predictor of a reduced risk of type 2 diabetes than high 25(OH)D for both sexes, whereas high IGF-1 concentrations predicted a decreased risk only in men.
CONCLUSIONS/INTERPRETATION:
High serum 25(OH)D concentrations predict a reduced risk of type 2 diabetes in individuals with prediabetes, but not NGT. There were no significant interactions between 25(OH)D and IGFBP-1 or IGF-1 in terms of risk of diabetes. Our data suggest that vitamin D supplementation should be evaluated for the prevention of type 2 diabetes in prediabetic individuals.
AuthorsA Deleskog, A Hilding, K Brismar, A Hamsten, S Efendic, C-G Östenson
JournalDiabetologia (Diabetologia) Vol. 55 Issue 6 Pg. 1668-78 (Jun 2012) ISSN: 1432-0428 [Electronic] Germany
PMID22426800 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Somatomedins
  • Vitamin D
  • 25-hydroxyvitamin D
Topics
  • Adult
  • Diabetes Mellitus, Type 2 (blood, metabolism, pathology)
  • Female
  • Glucose Intolerance (blood, metabolism, physiopathology)
  • Glucose Tolerance Test
  • Humans
  • Male
  • Middle Aged
  • Prediabetic State (blood, metabolism, physiopathology)
  • Somatomedins (metabolism)
  • Vitamin D (analogs & derivatives, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: